We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 923

Gotta pass the smell test, too

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • June 30 2014

A Florida court recently let a claim proceed under the Americans with Disabilities Act ("ADA"), even though the employee had been terminated for a

Auto makers flatten patent troll

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • October 7 2013

On August 9, 2013 the Federal Circuit decided Taurus IP, LLC v. DaimlerChrysler Corp., 2013 U.S. App. LEXIS 16507 (Court of Appeals, August 9, 2013

After the Supreme Court's Limelight decision, attention may shift to contract analysis in patent cases

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • July 2 2014

In Limelight Networks, Inc. v. Akamai Tech., Inc., the Supreme Court unanimously held that there can be no liability for induced infringement of a

How the Supreme Court decision in Alice Corp. v. CLS Bank undermines the USPTO subject matter eligibility guidance

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • June 24 2014

On June 19, 2014, the Supreme Court issued its decision in Alice Corp. v. CLS Bank International, finding that patents directed to "a

USPTO asks for patent subject matter eligibility comments by July 31, 2014

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • June 30 2014

In a June 30, 2014 Federal Register Notice, the USPTO requested public comments by July 31, 2014 on patent subject matter eligibility under the

District Court upholds FTC Hart-Scott-Rodino rules for pharmaceutical patent transfers

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • June 26 2014

A federal court has upheld the validity of the FTC's recent rules for reporting certain transfers of exclusive patent rights in the pharmaceutical

Supreme Court rejects President’s recess appointments as unconstitutional

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • June 26 2014

In a long-awaited monumental opinion, the Supreme Court today held unanimously that President Obama's purported "recess appointments" to the National

Why are method of treatment claims and method of manufacture claims subject to scrutiny under the USPTO patent subject matter eligibility guidance?

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • July 15 2014

The USPTO has asked for written comments on its patent subject matter eligibility guidance by July 31, 2014. In this article, I discuss why

Recent court decision may impact 340B Drug Pricing Program "Mega-Reg"

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • June 23 2014

A federal district court invalidated the first regulation published by the U.S. Department of Health and Human Services (HHS) addressing the 340B

Now I have to allow insubordination and verbal abuse too?

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • June 9 2014

Several weeks ago, in both a tongue-in-cheekand concerned fashioned, we wrote about a federal court decision that concluded an employer had to